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ABSTRACT 
The chemistry and toxicology of phosgene are reviewed at length. 
Manufacture, physical and chemical properties and industrial 
application of this important chemical intermediate are presented. Both 
acute and chronic exposure studies on animals and some human 
exposure data are also discussed. Pathology of phosgene poisoning and 
reliable therapeutic measures are critically examined. 
1. INTRODUCTION 
Phosgene, an extremely toxic chemical, also known as carbonyl chloride, has 
always been treated with great respect by its producers. Their concern over dangers 
associated with handling this versatile product, used as the first poisonous gas in World 
War I (later replaced by mustard gas), led to the formation in 1972 of the Chemical 
Manufacturers Association's first Chemical Safety panel.' 
Phosgene is under intense scrutiny, worldwide, in part because it is the key 
reactant, together with methylamine, for producing toxic methylisocyanate (MIC). 
The detrimental effects of MIC came to light in Bhopal, 1ndia.l.' Since that accident, 
many phosgene manufacturers and their customers have been reassessing their 
procedures for handling and using this important but hazardous chemical. Phosgene 
Aso can be produced from the burning of somi PVC-type plastics along with other 
chemicals. Attempts are being made to eliminate those plastics from use as building 
 material^.^ 
2. PHYSICAL AND CHEMICAL PROPERTIES 
Phosgene is a colourless, low-boiling liquid with an odour at 0.5 ppm in air 
resembling that of new-mown hay. Phosgene is soluble in aromatic and aliphatic 
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hydrocarbons as well as organic acids and esters. It is slowly hydrolyzed by pure water. 
Table 1 lists some of its other physical properties. 
Table 1. Some physical properties of phosgene3. 
--- 
Property -- Value 
Molecular Weight 98.92 
Melting Point, "C 
Boiling Point, "C 
Specific gravity at 4OC 
Vapour Pressure at 2 R ,  psi 





Phosgene is manufactured from highly refined carbon monoxide which is produced 
from synthetic gas, coke or charcoal, or natural gas. High purity carbon monoxide is 
reacted with chlorine gas in the presence of activated charcoal. The reaction with, 
chlorine is rapid and exothermic. After condensation of phosgene, the remaining 
product gases are scrubbed with sodium hydroxide solution to destroy any uncondensed 
phosgene. Product specifications and standards are as  follow^'^. phosgene (min.), 
99%; chlorine (free), max., 0.1 per cent; HCl,  max., 0.2 per cent. 
The output of phosgene is high and has been estimated to be 2.122 billion pounds 
in 1986 alone.' With few exceptions U.S. phosgene producers use virtually all of their 
output captively as an intermediate to synthesize toluene diisocyanate (a polyurethane 
building block), polycarbonates, drugs and pesticides. Phosgene is classified as a Class 
A poison and shipping it by truck or rail requires special containers. The procedure 
is both hazardous and costly.' As another alternate to the shipment of phosgene, 
modules are available that permit even small chemical manufacturers to install a 
phosgene generator on site. 
In addition to reducing the chance of a release of phosgene, many producers are 
reducing inventory by as much as 50 per cent and are interested in developing less 
toxic alternatives to phosgene. For Example, diphenylcarbonate is not as toxic, requires 
no waste treatment, and makes a readily transportable product. However, 
diphenylcarbonate costs more than three times as much as phosgene. Carbonyl 
Figure 1. 
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diimidazole (Fig. 1) is another subsitute for phosgene, but it is unstable and expensive. 
It does not appear probable that there will be any large-scale replacement for phosgene. 
4. COMMERCIAL USES OF PHOSGENE 
Most of the phosgene produced in industry (approximately 85 per cent) is used 
to synthesize organic isocyanates by reaction with amines. Polycarbonate formation 
via reaction with Bisphenol A is responsible for approximately 6 percent of the annual 
total, with the remainder of the phosgene being used to synthesize other chemical 
intermediates, drugs, and pesticides.6 Some typical reactions of phosgene are shown 
in Table 2. 
Table 2.Typical reactions of phosgene 
- - - - -- -- - -- 
Reactant Product 
Cadmium Sulfide Carbonyl Sulfide 
Calcium Oxide Calcium Chloride 
Titanium Oxide Titanium Chloride 
Fenic Phosphate Phosphorous Oxychloride 
Aluminum Chloride Complex 
Ammonia Urea, Cyanuric Acid, Cyanelide 
Primary Arnines lsocyanates 
Secondary Amines Carbamoyl Chlorides 
Amino Acids Chloroformate Derivatives 
Polyols Polycarbonates 
Carboxylic Acids Acid Chlorides 
Water Hydrochloric Acid 
(i) Organic Isocyanates 
The prominent polyfunctional isocyanates manufactured by reaction with the 
appropriate amine are : Toluene diisocyanate (TDI) (Fig. 2) and Methylene 
bis-phenylisocyanate (Fig. 3). 
Figure 2. Figure 3. 
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These and other polyfunctional isocyanates are reacted with glycols to form 
polyurethanes, useful in forming elastic fibers, tough coatings, and synthetic leathers. 
Methylisocyanate (MIC), CH,-N=C=O, the chemical released in Bhopal, is an 
intermediate in the production of pharmaceuticals and such large scale pesticides as 
the nematocide carbofuran. 
(ii) Polycarbonates 
Phosgene is reacted with a polyol, usually Bisphenol A, to form the 
polycarbonates, which have widespread use in food contact, automotive, medical, 
and construction markets. 
The polymers are used in numerous molded and extruded products such as street 
light covers, safety helmets, and break-resistant windows. 
(iii) Others 
The chloroformates are versatile chemical intermediates. The carbonic esters 
have significant uses in pharmaceuticals. Cyclic ethylene carbonate is often used in 
preparing solutions of polymers. 
5. WORKPLACE EXPOSURE 
Large-scale production of phosgene began only in the 1950s with the advent of 
the polyurethanes and the polycarbonates. National Institute of Occupational Safety 
and Health (NIOSH) estimated that 10,000 U.S. workers are potentially ,exposed to 
phosgene, especially during its production and subsequently during the synthesis of 
toluene dii~ocyanate.~ Phosgene levels in the air in workplaces where synthetic 
processes involving phosgene take place are reported to be as high as 0.4 ppm. The 
Occupational Safety and Health Administration has not issued a workplace exposure 
standard for phosgene, but the Agency has put into effect a special emphasis program 
that includes phosgene fa~ilities.~ 
Because of its irritating effects on the respiratory tract at levels slightly above 
0.1 ppm, a time-weighted average Threshold Limit Value (TLV) of 0.1 ppm is 
recommended by American Conference of Governmental, Industrial Hygienists 
(ACGIH). These levels have been shown to include tolerance.' Personnel in industry 
are trained to recognize the odour of phosgene (odour detection limit is considered 
to be 0.5 ppm) and to report any such odour immediately. The U.S. National Academy 
of Sciences lists a 90-day atmospheric limit for use in Submarines of 0.05 DDm and a 
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Douglas Aircraft continuous atmospheric limit of 0.04 ppm.9 Most other countries, 
including the USSR and the Council for Europe, have adopted 0.1 pprn or its mglm3 
equivalent Belgium, Holland, Romania, Sweden, and Switzerland have opted to 
adhere to a 0.05 pprn limit.9 
Exposure to phosgene may result not only from its use in the chemical industry, 
but also as a result of the decomposition in air of chlorinated organics. Hydrogen 
chloride is usually the principal decomposition product from such compounds, although 
a static system of PVC heated to high temperatures produced 0.2 to 1.6 milligrams 
of phosgene per gram of PVC.~ Phosgene may be the chief product of 
photodecomposition. Vapours of degreasing chlorocarbons in air near heliarc welding 
of aluminum may be largely converted to phosgene (1 to 3 pprn levels have been 
detected). While the rate of formation of phosgene often is not known, mathematical 
modeling has suggested that, for example, in PVC combustion, phosgene formation 
in considerable amounts but at slow rates can occur at temperatures of about 600°C. 
However, if the gases came in contact with metallic chlorides which are formed from 
copper, iron and elemental carbon in the form of soot or carbonized materials, the 
rates of formation of phosgene would be greatly enhanced via a catalytic action. 
Similarly, under conditions of combustion, dangerous levels of phosgene can be 
reached within a fraction of a minute.'' 
Since extensive precautions are taken by those who use phosgene, most incidences 
of high exposure occur as a result of leaks and spills. One large plant manufacturing 
MIC reported a total of 107 in-plant losses of phosgene during a recent five-year 
period." 
6. TOXICOLOGY 
The toxicity of phosgene in animals and dose response relationships have been 
reviewed in detail elsewhere. Observations clearly indicate that the sensitivity to 
phosgene toxicity varies with the species and increases where comparisons have made 
in the following order: < goat, < rat, < mouse, < man, < cat, < monkey.'' 
(i) Animal Exposures 
Most studies on phosgene toxicity have been carried out on 
(a) Acute Exposures 
Alveolar pulmonary edema was observed13 in rats 48 hours after exposure to 5 
pprn for 10 minutes. The lowest dose rate to produce a widening of pulmonary 
interstices was 25 pprn per minute. 
Concentrations as low as 0.5 pprn for 2 hours caused definite pathological changes 
in the lungs of rats sacrificed 96 hours after exposure. Some abnormalities were 
still present 3 months after a 2 pprn esposure for 80 minutes l2 
From a wide variety of studies1' it became clear that differences in airway structures 
have to be taken into account when extrapolating from animals to man. For 
example, absorption occurs mainly in the nasal passages of rabbits and 
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comparatively little reaches the lung as a result of the complicated structure of 
the rabbit's nasal airway. In manwhere the nasal structure is less complex phosgene 
can reach and damage the deeper regions of the lung.14 
Several studies have demonstrated13 that phosgene inhaled at low concentrations 
by test animals results in a decreased susceptibility to subsequent and otherwise 
acute, edema-producing doses. Phosgene at 1 ppm for 6 hours not only induced 
tolerance against the acute effects of a subsequent exposure, but also protected 
the host against other edema-producing agents such as ozone. 45 This development 
of tolerance, however, is thought to be the triggering mechanism of irreversible 
lung changes when there is daily exposure to low levels that produce no obvious 
acute response. 
(b) Chronic Exposures 
Phosgene has not been adequately studied with respect to chronic toxicity, 
including carcinogenicity and mutagenicity. Probably this lack of satisfactory data 
reflects the difficulties attendant to conducting valid tests with a highly reactive, acutely 
toxic compound which produces corrosive HCl on contact with water. Phosgene may 
not be systemically absorbed, but rather is thought to react with tissues at the site of 
contact. Prolonged exposures in the workplace to phosgene will probably not occur 
above levels of 3 to 4 ppm since immediate eye and respiratory imtation can result 
at this level. 
Cameron and associates16 reported that exposure at 0.2 ppm, for 5 hourslday, for 
5 consecutive days caused pulmonary edema. and histopathological abnormalities in 
41 per cent of the exposed animals (goats, cats, rabbits, guineapigs, rats, mice). 
ACGIH cited these data as a major consideration in recommending a TLV of 0.1 
ppm. Repeated exposures of cats to 5 to 6 ppm for 10 minutes every day caused no 
greater lung damage after. 40 days than after 2 days.' 
(ii) Human Exposures 
The poisonous effects of phosgene in man were first seen during World War I 
when thousands of soldiers were exposed to the gas.n Follow-up examinations of 
these soldiers were not informative since it was impossible to identify unequivocally 
the noxious gas to which the individual was exposed; in many cases gas mixtures such 
as chlorine plus phosgene and subsequently nitrogen mustards were involved. 
At present, toxic phosgene exposure involves isolated accidents where workers 
in the process of manufacturing and use of phosgene are exposed to the gas. 
Occupational or bystander exposure to phosgene occurs primarily via inhalation. 
It is generally accepted that phosgene may cause chronic lung disease in man 
though no quantitative data are available on the dosage which may produce permanent 
pulmonary damage.18 
6.1 Vagal Reflexes 
In most cases phosgene poisoning may involve the inhalation of doses below 3 
ppm.'9 Mild symptoms of imtation occur such as tickle in the throat, irritant cough 
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and retrosternal pressure pain; patients also complain of weakness at the knees and 
watering eyes. These symptoms abate rapidly, however, within 24 hours and the 
patient is then relatively free from symptoms throughout the clinical latent phase.19 
Phosgene inhaled in concentrations of 3 ppm can trigger a vagal reflex within the 
bronchial tree.20p21 Respiration becomes frequent and shallow; arterial oxygen is 
decreased. The partial pressure of arterial carbon dioxide (PaCO,) shows a tendency 
to increase and blood pH decreases. Bradycardia and occasionally sinus arrhythmia 
occur and the systemic blood pressure tends to 
6.2 Pathology of Phosgene Poisoning 
Toxic injury to the lung from phosgene poisoning results in increased water 
permeability of the lung capillaries to the endothelium and edema.19y2' Initial increase 
in water efflux capillary to interstitium are mostly compensated by increased lymphatic 
clearance. When the lung's ability to clear excess fluid is exceeded, fluid volume in 
the lung interstitium rises and water leaks through the alveolar epithelium into the 
alveolar spaces.18 When a sufficiently large amount of fluid has collected in the lung, 
edema becomes apparent both directly and indirectly. Gas exchange becomes 
insufficient, and the fluid gradually rises from the alveoli into the proximal segments 
of the respiratory tract. Due to increasing defects within the blood-air bamer, the 
edema fluid becomes richer in protein content. The mucous membrane of the bronchi 
becomes necrotic and is shed, further impeding respiration. Leucocytes migrate into 
the bronchiole walls and into the alveolar interstices.18 
The pulmonary toxic effects begin immediately upon inhalation of 
phosgene.18.19.261" A report on cardiopulmonary p a t h ~ ~ h y s i o l o g ~ ~ ~  suggests that the 
terminal airways, alveolar lining layer and alveolar epithelial layer are affected first. 
Initial damage at these anatomical sites is supported by the findings of histopathological 
abnormalities at the air-blood barriep,28 and in the terminal airways.29 Pulmonary 
edema is considered a late pathologic effect of phosgene exposure except at very high 
and low doses. High exposure levels can result in death before pulmonary edema 
developsZ0 and low exposure produces localized acute inflammation of the lung." 
A very high doses (200 ppm) in acute poisoning phosgene passes through the 
blood-air barrier, reaches the lung capillaries and reacts with blood constituents. 
Hemolysis in the pulmonary capillaries occurs with hematin formation. Congestion 
by erythrocyte fragments, and stoppage of capillary circulation is observed. Death 
occurs within a few'minutes from acute overdistension of the right heart, often before 
pulmonary edema can develop.30 A summary of the symptoms observed at various 
dose levels of phosgene poisoning is shoin in Table 3. 
7. THERAPEUTIC APPROACHES IN PHOSGENE POISONING 
Each instance of phosgene poisoning must be considered as a highly individualized 
situation. The therapy must be adjusted to the particular clinical situation. 
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Table 3. Effects of inhaled phosgene 
Effect Concentration of Phosgene 
Perception of odour 0.4 PPm 
Recognition of odour 
Signs of irritation in eyes, 
nose, throat and bronchi 
Beginning lung damage 30 ppm-min 
Clinical pulmonary edema 150 ppm-nun 
LCT, soo ppm-min 
LC% 1300 ppm-min 
7.1 Positive Ventilation With Oxygen 
There are clinical reports which show the beneficial effects of positive pressure 
ventilation with oxygen during phosgene e ~ ~ o s u r e . ~ ~ ~  The action is assumed to be 
due to the elevated alveolar pressure whivh counteracts the filtration pressure of the 
lung capillaries, reopens collapsed alveoli, reduces shunt volume, enlarges functional 
residual capacity and improves oxygenation of the blood. The disadvantages of positive 
pressure ventilation with oxygen are a reduction of cardiac output, an increase in lung 
water due to impeded drainage, an overdistension of normal alveoli and a potential 
of damaged alveolar walls which can result in pneum~thorax.~~ 
7.2 Glucocorticoids 
Clinical reports on the effect on glucocorticoids are promising34935 though 
controlled (blind) studies are lacking. While a few clinicians suggest the inhalation of 
glucocorticoid-aerosol, the majority favors combined inhalation and systemic 
administration, due to the uncreatainty weather the inhaled glucocorticoids reach the 
affected alveoli in adequate amounts. The general recommendation is to administer 
glucocorticoids as early as possible after the phosgene inhalation 
The beneficial effects of glucocorticoids in phosgene induced edema may be due 
to the increase of macrocortin synthesis (leading to inhibition of phospholipase A, 
activity and to inhibition of prostaglandin E, release); stabilization of lysosomes; 
inhibition of plasminogen-activation; inhibition of tissue-macrophages; enhancement 
of prostaglandin E, activity; and positive inotropic effect of myocardium.34735 
7.3 Sedatives and Analgesics 
These agents have been recommended for all forms of pulmonary edema. They 
lower basal metabolism and thereby oxygen demand; on the other hand some like 
morphine depress the respiratory 
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7.4 X-ray 
Chest X-ray radiograms facilitate the early diagnosis of beginning pulmonary 
edema.38~ince the speed of development of toxic pulmonary edema is inversely 
proportional to the inhaled phosgene dose, such X-ray photographs must be taken 
about 2 hours after the inhalation of very high doses of phosgene. A radiogram taken 
8 hours later will suffice if exposure to low concentrations has occured. Strategy of 
therapy is related to dose. Exposure doses below 25 ppmtmm can be regarded as 
harmless.30 
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